Skip to main content
| News

Owkin heads to Basel

15.10.2021

The Franco-US startup Owkin is growing in the Basel Area. The company develops solutions for the life sciences industry on the basis of Artificial Intelligence and Machine Learning.

The founders of Owkin: Thomas Clozel (left) and Gilles Wainrib (img: Owkin)

Owkin is seeking to secure growth across Europe and further beyond. For this reason, the startup is setting up a new branch office located in Basel. Before now, the company operated out of locations in France, the USA and the UK, developing solutions for the life sciences industry on the basis of Artificial Intelligence (AI) and Federated Learning. The latter is a field of Machine Learning. With these solutions, the company aims to drive forward developments in the area of precision medicine in particular.

In Federated Learning, the focus is on working with various local data sets, whereas a central data set is used in Machine Learning. This has advantages in terms of data protection. Owkin brings researchers and hospitals together with life science companies via its platform, encouraging them to collaborate on the discovery and development of new drugs in the process. For this, the company uses patient data that is protected by Federated Learning. With this approach, Owkin has already raised 70 million US dollars in venture capital.

The company was founded in 2016 by Gilles Wainrib and Thomas Clozel. Wainrib is an expert in the use of AI in biological areas, while Clozel works as a doctor in the field of clinical research. He is the son of Martine and Jean-Paul Clozel, the founders of Actelion and Idorsia based in Allschwil in the canton of Basel-Landschaft.

Offering one of Europe’s largest life sciences clusters, Basel is highly attractive as a location to Owkin. Here, the company can find numerous potential partners that stand to benefit from its solutions. Moreover, Owkin is looking to capitalize on the exceptionally well-educated specialists in the region to support its further growth course. “Owkin‘s mission is to develop cutting-edge AI technologies that help doctors to find the right treatment for every patient. But to achieve that, we must work closely with pharmaceutical partners, hospitals and research institutions across the world”, explains Sezai Taskin, SVP of Strategic Business Development at Owkin, who is based in Basel, before adding: “Establishing a presence in Basel – Owkin‘s fourth, after France, the United States and the United Kingdom – will enable us to connect with leading partners, while also helping to attract more of the best talent possible.”

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

What can artificial intelligence do for health?
Basel Area Business & Innovation, Digital Health, Innovation, Life Sciences / biotech, Medtech

What can artificial intelligence do for health?

Algorithms help diagnose and treat diseases, discover new drugs and personalize prevention. Thus, the potential of artificial intelligence has been...

Read More
EvokAI to acquire Advancience
Basel Area Business & Innovation, Digital Health, Innovation, Invest, Medtech

EvokAI to acquire Advancience

EvokAI Creative Labs Inc. has agreed a deal to acquire Advancience. The diagnosis profiles enhanced by Artificial Intelligence (AI) developed...

Read More
DayOne healthtech accelerator launches new offering
Basel Area Business & Innovation, Digital Health, Innovation, Medtech

DayOne healthtech accelerator launches new offering

DayOne shares the launch of DayOne Accelerator 2.0, marking a transition to three verticals that will enable the growth of...

Read More
Basel Area sets new record for new company settlements
Advanced Manufacturing/AI, Basel Area Business & Innovation, Digital Health, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

Basel Area sets new record for new company settlements

For Basel Area Business & Innovation, 2021 was a record year. Last year, the investment and innovation promotion agency supported...

Read More
“To create the future of health, we need to come together as an ecosystem”
Basel Area Business & Innovation, Digital Health, Invest

“To create the future of health, we need to come together as an ecosystem”

The future of health has already begun – but where does it lead us to? Patricia Gee is director of the...

Read More
The gravitational attraction of the Basel Area – Europe’s leading healthcare hub.
Basel Area Business & Innovation, Digital Health, Innovation, Invest

The gravitational attraction of the Basel Area – Europe’s leading healthcare hub.

Breakthrough advances in digital technology and artificial intelligence are transforming how we manage our health, and helping data-driven life science...

Read More

Do you have a question? We'd like to hear from you.